Hims & Hers Sees Stock Surge Amid Trump’s FDA Appointment Speculations

In a significant development in the healthcare and wellness sector, shares of Hims & Hers Health Inc. experienced a notable rise following the news of former President Donald Trump’s likely appointment of a new FDA chief, who is perceived as a potential supporter of the company’s business model. This surge has sparked considerable interest among investors and analysts alike, reflecting optimism about future growth and regulatory alignment.

Continue reading